8 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
for Treatment & ... Cell Arteritis ... (GCA) • Takayasu's ... #Treatment #ACR2021 ... #Guidelines #algorithm
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... Algorithm - ACR ... /VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... (GCA) - Vasculitis ... Management Algorithm ... #Management #Treatment ... #ACR2021 #Guidelines
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Algorithm - ACR ... /VF 2021 Guidelines ... of Preference (Can ... #Treatment #ACR2021 ... #Guidelines #algorithm
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Algorithm - ACR ... /VF 2021 Guidelines ... • Severe Disease ... #Treatment #ACR2021 ... #Guidelines #algorithm
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
incomplete Kawasaki Disease ... purposes of this algorithm ... ≥2.5, coronary arteries ... effusion, or z scores ... echo is positive, treatment
Relapsing Polychondritis

What is it?
Recurrent inflammation of the cartilage in the body (Autoimmune disorder)

Who?
• Most frequently: 40
immunologically mediated diseases ... Polyarteritis Nodosa, GCA ... Sarcoidosis • Behcet disease ... affected tissue Treatment ... rheumatology #diagnosis #management